The Value of Decision Analytical Modeling in Surgical Research
- 1 March 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 269 (3) , 530-536
Abstract
Objective: To illustrate how decision modeling may identify relevant uncertainty and can preclude or identify areas of future research in surgery. Summary Background Data: To optimize use of research resources, a tool is needed that assists in identifying relevant uncertainties and the added value of reducing these uncertainties. Methods: The clinical pathway for laparoscopic distal pancreatectomy (LDP) versus open (ODP) for nonmalignant lesions was modeled in a decision tree. Cost-effectiveness based on complications, hospital stay, costs, quality of life, and survival was analyzed. The effect of existing uncertainty on the cost-effectiveness was addressed, as well as the expected value of eliminating uncertainties. Results: Based on 29 nonrandomized studies (3.701 patients) the model shows that LDP is more cost-effective compared with ODP. Scenarios in which LDP does not outperform ODP for cost-effectiveness seem unrealistic, e.g., a 30-day mortality rate of 1.79 times higher after LDP as compared with ODP, conversion in 62.2%, surgically repair of incisional hernias in 21% after LDP, or an average 2.3 days longer hospital stay after LDP than after ODP. Taking all uncertainty into account, LDP remained more cost-effective. Minimizing these uncertainties did not change the outcome. Conclusions: The results show how decision analytical modeling can help to identify relevant uncertainty and guide decisions for future research in surgery. Based on the current available evidence, a randomized clinical trial on complications, hospital stay, costs, quality of life, and survival is highly unlikely to change the conclusion that LDP is more cost-effective than ODP.Keywords
This publication has 30 references indexed in Scilit:
- Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force ReportValue in Health, 2015
- Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysisJournal of Comparative Effectiveness Research, 2013
- When is enough evidence enough? – Using systematic decision analysis and value-of-information analysis to determine the need for further evidenceZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2013
- Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1Value in Health, 2012
- Evaluation and stages of surgical innovationsThe Lancet, 2009
- The challenges faced in the design, conduct and analysis of surgical randomised controlled trialsTrials, 2009
- Cost-effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethraJournal of Tissue Engineering and Regenerative Medicine, 2007
- When are randomised trials unnecessary? Picking signal from noiseBMJ, 2007
- Anecdotes that provide definitive evidenceBMJ, 2006
- Perspectives of Evidence-Based SurgeryDigestive Surgery, 2003